Results 121 to 130 of about 23,483 (205)

Design of soluble HIV-1 envelope trimers free of covalent gp120-gp41 bonds with prevalent native-like conformation. [PDF]

open access: yesCell Rep
Zhang P   +19 more
europepmc   +1 more source

A comprehensive engineering strategy improves potency and manufacturability of a near pan-neutralizing antibody against HIV. [PDF]

open access: yesStructure
Sajadi MM   +45 more
europepmc   +1 more source

Assembly of CCR5 with gp120 inhibits the HIV infectivity specifically in T cells. [PDF]

open access: yesSci Rep
Appiah-Kubi J   +12 more
europepmc   +1 more source

HIV-1 Integrase T218I/S Polymorphisms Do Not Reduce HIV-1 Integrase Inhibitors' Phenotypic Susceptibility. [PDF]

open access: yesAIDS Res Hum Retroviruses
Rodríguez-López ER   +9 more
europepmc   +1 more source

Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV-workshop report. [PDF]

open access: yesNPJ Vaccines
Maciel M   +13 more
europepmc   +1 more source

Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants. [PDF]

open access: yesCell Rep, 2022
Chen Z   +23 more
europepmc   +1 more source

Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys. [PDF]

open access: yesCell, 2022
Le Nouën C   +21 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy